When Chromatin Wobbles, Cells Pay a Metabolic Price, Study Finds

In the crowded interior of a yeast cell, two systems that rarely share the spotlight are now being cast as intimate conversational partners. One is chromatin, the DNA-and-protein complex that packages the genome and decides which genes can be read. The other is TORC1, the mechanistic target of rapamycin complex 1, a kinase hub that senses nutrients and dictates how fast the cell grows. A new study published in PLOS Genetics by Vinoth Sigamani, Mohd Yousuf, Daniel L. Johnson, Brian D. Strahl, and R. Nicholas Laribee shows that the traffic between these two systems runs in both directions. For years, biologists have known that TORC1 can reach into the nucleus and reshape chromatin to help cells adapt when food supplies fluctuate. What the new work demonstrates is that chromatin talks back: when its structural integrity falters, TORC1 slips out of control, and the consequences ripple all the way into the cell’s power plants, the mitochondria.

The team’s entry point was a subtle mutation in histone H3, one of the core protein spools around which DNA is wound. They changed lysine 37, an amino acid predicted to make direct contact with the DNA backbone, into an alanine, creating the H3K37A mutant. The idea was straightforward: if this residue helps grip DNA, removing it should loosen the wrap. That is precisely what happened, but the downstream effects were anything but subtle. Cells carrying H3K37A began degrading their histones, a hallmark of chromatin instability, and their TORC1 kinase went into overdrive. Hyperactive TORC1 is normally a sign of a cell awash in nutrients; here it appeared without any change in the food supply, driven instead by a single altered amino acid in the genome’s packaging material.

To understand whether this TORC1 hyperactivation was merely a side effect or something with real consequences, the researchers threw a pharmacological wrench into the pathway. When they inhibited TORC1 in H3K37A cells, the cells died. This was the study’s first surprise, because TORC1 inhibition is usually survivable, if uncomfortable, for yeast. The toxicity was not a general property of chromatin instability, either. The team compared H3K37A to cells carrying wild-type histone H3 in which chromatin stability had been undermined by other means. Those cells also lost histones and also showed hyperactivated TORC1, yet they tolerated TORC1 inhibition just fine. Something about the H3K37A mutation specifically, rather than loose chromatin per se, primed cells for catastrophe when the nutrient-sensing pathway was throttled back.

The genetic interactions sharpened that conclusion. When the researchers combined H3K37A with mutations that destabilize chromatin in an otherwise wild-type histone context, the defects did not simply add up; they compounded. Histone loss grew worse, TORC1 activity climbed higher, and lethality during TORC1 inhibition became more severe. This synergy suggests that H3K37A and general chromatin instability damage overlapping but distinct aspects of genome packaging, and that the cell can absorb a certain amount of damage from either source alone. Pushed from both directions at once, the buffering capacity collapses. The result is a dose-response relationship between chromatin integrity and TORC1 control that had not been appreciated before, positioning histone-DNA contacts as an upstream restraint on one of the cell’s most consequential signaling pathways.

Why would a wobbly nucleosome care about a nutrient kinase? The answer, according to transcriptome profiling, lies in the mitochondria. The gene expression analysis revealed that H3K37A cells misregulate mitochondrial retrograde signaling, a stress-response program through which dysfunctional mitochondria inform the nucleus and trigger compensatory metabolic rewiring. In yeast, this pathway is classically activated when respiratory function falters, allowing cells to reconfigure carbon metabolism and survive on fermentation. In the mutant, this program was already deregulated at baseline, and inhibiting TORC1 made the derangement dramatically worse. The combination of a strained retrograde response and a suppressed growth pathway proved lethal, indicating that the two systems normally cooperate to keep mitochondrial stress manageable during metabolic adaptation.

The mechanistic thread connecting chromatin to mitochondrial function turned out to be protein import. The researchers found that H3K37A cells were defective in importing at least one oxidative phosphorylation, or OXPHOS, subunit into the mitochondria. OXPHOS complexes are assembled from components made in the cytosol and threaded through mitochondrial membrane transport machinery; a bottleneck at this step starves the respiratory chain of parts and undermines energy production. Defective import of an OXPHOS subunit provides a concrete, testable link between the nuclear defect and the mitochondrial phenotype, explaining how a histone mutation expressed in the nucleus can compromise the electron transport chain embedded in the inner mitochondrial membrane.

Two rescue experiments cemented the causal chain. First, when the team inactivated the retrograde pathway itself, the toxicity of TORC1 inhibition in H3K37A cells was prevented. This may seem paradoxical, since the retrograde response is usually framed as protective, but a misfired or incomplete retrograde program can apparently be worse than none at all, pushing cells into a metabolic configuration incompatible with reduced TORC1 activity. Second, neutralizing reactive oxygen species, the chemically reactive byproducts of mitochondrial electron leakage that accumulate when respiration goes awry, also blocked the lethality. Together, these results sketch a coherent pathway: chromatin instability deregulates retrograde signaling, retrograde dysfunction impairs mitochondrial protein import and respiratory capacity, ROS accumulate, and the cell crosses a viability threshold when TORC1 is simultaneously inhibited.

The conceptual payoff is the demonstration of bidirectional communication between chromatin and TORC1. The canonical view has TORC1 sitting at the top of a signaling hierarchy, phosphorylating downstream effectors that include chromatin-modifying enzymes and transcriptional regulators, thereby imposing nutrient-dependent patterns of gene expression. The new data invert part of that picture. Chromatin stability, embodied in a single histone residue that touches DNA, acts as an input that constrains TORC1 output. Lose that constraint and TORC1 hyperactivates, independent of nutrient status. This reframes chromatin not merely as a passive target of metabolic signaling but as an active participant in metabolic homeostasis, with histone-DNA contacts serving as a structural sensor whose integrity feeds back into growth control.

The study also assigns a previously unknown job to histone H3 lysine 37. Beyond its structural role in the nucleosome, the residue appears to have an additional functionality that protects mitochondrial regulation during metabolic stress adaptation. That kind of dual assignment is becoming a theme in chromatin biology, where histone residues are increasingly recognized as nodes connecting genome architecture to cellular physiology. It also raises evolutionary questions about why a DNA-contacting residue would be conserved partly for its role in mitochondrial governance, and whether analogous histone mutations in other organisms, including human disease variants, produce comparable metabolic vulnerabilities.

For the broader research community, the work opens several practical avenues. Cells with compromised chromatin may be silently hyperactivating TORC1, confounding experiments that interpret TORC1 activity purely as a readout of nutrient availability. Conversely, therapies that inhibit TOR signaling, a strategy under active investigation in cancer and aging research, could carry unappreciated risks for cells with chromatin instability, a common feature of tumors. And the mitochondria-centered toxicity mechanism suggests that antioxidants or interventions targeting retrograde signaling might mitigate such risks in susceptible contexts. What began as a question about a single lysine in a histone tail region has ended as a demonstration that the genome’s packaging material helps guard the cell’s energy supply, and that when the packaging fails, the growth-control machinery and the mitochondria fail with it.

Subject of Research: How chromatin stability regulates TORC1 signaling and mitochondrial homeostasis in yeast

Article Title: Chromatin stability safeguards mitochondrial homeostasis and restrains TORC1 signaling

Article References: Sigamani, V., Yousuf, M., Johnson, D. L., Strahl, B. D., & Laribee, R. N. (2026). Chromatin stability safeguards mitochondrial homeostasis and restrains TORC1 signaling. PLOS Genetics, 22(10), e1012330. https://doi.org/10.1371/journal.pgen.1012330

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012330

Keywords: chromatin, TORC1, histone H3, mitochondria, retrograde signaling, yeast genetics, reactive oxygen species, OXPHOS, nutrient signaling, histone degradation, PLOS Genetics, metabolic stress